Methods A thorough literature review was conducted to gather relevant studies and articles on the relationship between T2DM and sarcopenia
Currently available FDA-approved GLP-1 RAs include several monotherapy agents and one combination multi-agonist, the dual GLP-1/GIP agonist tirzepatide (Zheng et al., 2024)
Body Protection Compounds (BPC)-157 is a naturally occurring peptide that has been found to support connective tissue healing.*
1), with a special focus on the role of incretin-based therapy in combating obesity-related OSA
Value We provide the licensed prescribers, medical oversight, standardized protocols, and compliance structure required to deliver GLP-1 programs safely, ethically, and in full alignment with state and federal laws
10.1016/j.tips.2017.04.005 77 QinS.TangH.LiW.GongY.LiS.HuangJ.et al (2020)